JEFFREY L WADE

CIK 1225767 · President and COO · last filed 2024-07-08

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$600.6K

Companies

2

Total Filings

39

Lifetime Open-Market Net

$60.8K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
LXRX	President and COO	312,792	$1.92	$600.6K	$60.8K	38	2024-07-08
LEXICON PHARMACEUTICALS, INC. (LEXG) Delisted	EVP, Gen. Counsel	—	—	—	$0	1	2007-02-15

Recent Filings · Page 4 of 4

39 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2012-03-01	LXRX	Mixed	+13,791	-$8.8K	EDGAR
2012-02-17	LXRX	Grant (A)	—	$0	EDGAR
2011-02-25	LXRX	Mixed	+13,411	-$10.7K	EDGAR
2010-05-19	LXRX	Grant (A)	—	$0	EDGAR
2010-02-17	LXRX	Mixed	−7,314	-$14.0K	EDGAR
2009-08-14	LXRX	Tax (F)	−5,924	-$7.7K	EDGAR
2009-02-17	LXRX	Grant (A)	+44,800	$0	EDGAR
2008-02-11	LXRX	Grant (A)	—	$0	EDGAR
2007-02-15	LEXICON PHARMACEUTICALS, INC. (LEXG) Delisted	Grant (A)	—	$0	EDGAR

Showing 31–39 of 39

Prev Page 4 of 4

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.